[ad_1]
A vaccine from Pfizer and BioNTech, as well as from AstraZeneca and the University of Oxford, said the Scottish government study, announced Monday, dramatically reduces the number of hospitalizations for coronavirus infections.
Preliminary results of a study by researchers from Public Health Scotland and the University of Edinburgh and the University of Strathclyde show an 85 percent reduction in coronavirus infection among those vaccinated with the Pfizer / BioNTech vaccine caused by hospitalization due to Covid-19.
The AstraZeneca / Oxford vaccine reduced the number of people hospitalized with Covid-19 by 94 percent. The study was carried out in a population sample of 1.14 million people, based on the experience of vaccines administered in Scotland between 8 December and 15 February.
The researchers looked at the effects of both vaccines after the first few doses and compared them with statistics on the number of illnesses that required hospital treatment in groups that had not yet been vaccinated against the coronavirus.
The calculation methodology used in the study shows that in the age group over 80, which has been identified by the British Government’s Joint Committee on Vaccination (JCVI) as the most vulnerable population, the two vaccines reduced the number of serious infections for coronaviruses that require hospital treatment. by an average of 81 percent.
Professor Aziz Sheikh, director of research at the University of Edinburgh and head of the vaccine efficacy study in Scotland, described the results of the survey program as “very, very remarkable” in a statement released Monday.
He added that the study clearly showed that both the Pfizer / BioNTech vaccine and the AstraZeneca / Oxford vaccine were spectacularly effective in preventing serious illnesses caused by coronavirus infection.
According to Professor Sheikh, the results are very encouraging and provide a solid basis for optimism about the future.
The efficacy of vaccines has also been suggested by previous data analysis.
According to a study by the British Office of Statistics (ONS), that in England, the proportion of people over 80 who have antibodies against the coronavirus is the highest in the English population. The ONS analysis also directly indicated that the result of this study has a significant chance of showing the effectiveness of the UK vaccination campaign.
According to the UK vaccination schedule, the 80+ age group received the highest proportion of coronavirus vaccines.
Jonathan Van-Tam, England’s deputy chief medical officer, recently told BBC television that if very high-risk population groups were vaccinated in very large numbers, deaths from coronavirus epidemics and serious illnesses requiring hospital treatment could reduced by up to 99 percent. cent after both doses.
Since the start of the UK vaccination campaign on December 8, 17.6 million have received the first dose of the vaccine; this is one third of the total British adult population.
[ad_2]
